![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, September 15, 2010 11:18:04 AM
wrong? spend your day twisting words or whatever
did you see my Projection at all: FIVE PERCENT
naturally that is not everyone
yet, MOST will likely get tested anyway, and this projection is likely short term low milestone...
here they are again!!!!
If InoLife captures JUST 5% of the existing market share for Plavix and the 6M new prescriptions in the next 3 months, this is what the stock price would be at $250 cost:
$5.56
That's EBITDA, etc. But also without a multiple.
Lop off 40% for margin of error, and it's $3.34
Imagine if 50% market share, or 80%
legend:
5%Mkt share * 9M new Plavix users 3 months = 450,000
5%Mkt share * 48M Plavix users = 2.4M
128 OS
$250 cost
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM